SDF1 in the dorsal corticospinal tract promotes CXCR4+ cell migration after spinal cord injury
© Tysseling et al; licensee BioMed Central Ltd. 2011
Received: 9 December 2010
Accepted: 16 February 2011
Published: 16 February 2011
Stromal cell-derived factor-1 (SDF1) and its major signaling receptor, CXCR4, were initially described in the immune system; however, they are also expressed in the nervous system, including the spinal cord. After spinal cord injury, the blood brain barrier is compromised, opening the way for chemokine signaling between these two systems. These experiments clarified prior contradictory findings on normal expression of SDF1 and CXCR4 as well as examined the resulting spinal cord responses resulting from this signaling.
These experiments examined the expression and function of SDF1 and CXCR4 in the normal and injured adult mouse spinal cord primarily using CXCR4-EGFP and SDF1-EGFP transgenic reporter mice.
In the uninjured spinal cord, SDF1 was expressed in the dorsal corticospinal tract (dCST) as well as the meninges, whereas CXCR4 was found only in ependymal cells surrounding the central canal. After spinal cord injury (SCI), the pattern of SDF1 expression did not change rostral to the lesion but it disappeared from the degenerating dCST caudally. By contrast, CXCR4 expression changed dramatically after SCI. In addition to the CXCR4+ cells in the ependymal layer, numerous CXCR4+ cells appeared in the peripheral white matter and in the dorsal white matter localized between the dorsal corticospinal tract and the gray matter rostral to the lesion site. The non-ependymal CXCR4+ cells were found to be NG2+ and CD11b+ macrophages that presumably infiltrated through the broken blood-brain barrier. One population of macrophages appeared to be migrating towards the dCST that contains SDF1 rostral to the injury but not towards the caudal dCST in which SDF1 is no longer present. A second population of the CXCR4+ macrophages was present near the SDF1-expressing meningeal cells.
These observations suggest that attraction of CXCR4+ macrophages is part of a programmed response to injury and that modulation of the SDF1 signaling system may be important for regulating the inflammatory response after SCI.
Chemokines, originally described for their role in promoting the migration of leukocytes during inflammatory responses, have many well-established pro-inflammatory and pro-migratory roles in the immune system. More recently they have been found to have numerous important functions in the nervous system as well [1–3]. In the developing brain, neurons and glia express various chemokine receptors and are therefore potential targets for chemokine signaling [2, 3]. For example, neonatal oligodendrocyte maturation and myelination, axonal growth, neuronal proliferation and neuronal survival are just a few of the normal processes regulated by chemokines and particularly by one chemokine pair, stromal cell-derived factor-1 (SDF-1; also known as CXCL12) with its receptor CXC chemokine receptor 4 (CXCR4) [4–11].
After spinal cord injury (SCI) the blood-brain barrier is compromised leading to a large infiltration of macrophages. Beneficial as well as deleterious effects have been ascribed to immune cells that infiltrate the nervous system after neural injury, including SCI [12–18]. Since cells of both the nervous and immune systems express SDF1 and CXCR4, chemokine signaling between these cells could regulate spinal cord responses to injury. However, due to contradictory reports of SDF1/CXCR4 signaling in the spinal cord and following SCI, their role remains unclear [19–22]. In the adult spinal cord GABAergic neurons  and corticospinal motor neurons  reportedly express CXCR4. Further, levels of SDF1 mRNA increase 7 days after SCI suggesting a possible role in injury responses . We therefore sought to define the expression and possible function of SDF1 and its receptor, CXCR4 in the normal spinal cord and after SCI. We observed that in the normal spinal cord, SDF1 is expressed by the dorsal corticospinal tract (dCST) and by the meninges whereas ependymal cells express CXCR4. After SCI, infiltrating macrophages and perhaps ependymal cells, both of which express CXCR4, appear to migrate towards both the dCST and meningeal sources of SDF1. Another population of CXCR4+ cells remains in the ependymal layer after SCI. These observations suggest that this signaling system may help to regulate inflammatory responses after SCI, particularly in the dorsal spinal cord.
The transgenic mice used in this study (all kindly provided by Richard Miller, Northwestern University) were CXCR4-EGFP (CXCR4BAC::EGFP) and SDF-1-EGFP (SDF-1BAC::EGFP) from The Rockefeller University, New York, NY and The Gene Expression Nervous System Atlas (GENSAT) project, National Institute of Neurological Disorders and Stroke contract N01Nso2331 to The Rockefeller University, New York, NY http://www.gensat.org. All animal-related procedures were approved by the Northwestern University animal care and use committee.
Spinal cord injury
Adult mice are anesthetized using inhalation anesthetic (2.5% isofluorane in 100% oxygen which was administered using VetEquip Rodent anesthesia machine). After laminectomy at the T10 vertebral segment, the spinal cord was compressed dorsoventrally by the extradural application of a 24 g modified aneurysm clip for 1 min (FEJOTA mouse clip). After SCI, the skin was sutured using AUTOCLIP (9 mm; BD Biosciences, San Jose, CA). Bladders were manually emptied twice daily throughout the duration of the study. Post surgery and in the event of discomfort, Meloxicam (0.3 mg/kg, s.c., once daily) was administered. Gentamycin was administered once daily in the event of hematuria (20 mg/kg) subcutaneously for 5 d.
Dextran dye injection
Adult mice were anesthetized with Avertin and were injected with mini-ruby-conjugated BDA (Invitrogen) using a 10 μl Hamilton microsyringe fitted with a pulled-glass micropipette. The corticospinal tract was labeled with three injections (0.5 μl each) made at 1.0 mm lateral to the midline at 0.5 mm anterior, 0.5 mm posterior, and 1.0 mm posterior to bregma, and at a depth of 0.5 mm from the cortical surface. Animals were sacrificed 14 d after BDA injection and perfused.
Animal perfusions and tissue acquisition
Animals were sacrificed using an overdose of carbon dioxide and transcardially perfused with PBS followed by 4% paraformaldehyde in PBS. The spinal cords were dissected and either fixed overnight in 30% sucrose in 4% PFA or fixed for 2 hours in 4% PFA and dehydrated overnight in 30% sucrose. The spinal cords were then frozen in Tissue-Tek embedding compound and sectioned on a Leica (Deerfield, IL) CM3050 S cryostat at 20 μm.
Sections were rinsed with PBS thrice and then incubated with blocking solution (10% normal goat serum, 0.25% TritonX-100, 1% BSA in PBS) at room temperature for 1 hour. The sections were again rinsed thrice with PBS and incubated with primary antibody [(GFAP; 1:250; mouse monoclonal IgG1; Sigma), (CD11b; 1:200; rat monoclonal IgG2b; Serotec), (Nestin; 1:200; mouse monoclonal IgG1; Abcam), (NG2; 1:200; rabbit; Chemicon), (RC2; 1:8; mouse monoclonal IgM, DSHB) in blocking solution without NGS at 4 deg C overnight. The SDF1-EGFP and CXCR4-EGFP expression in these reporter mice was very strong and required no antibody amplification. After this, sections were rinsed thrice with PBS and incubated with Alexa Fluorconjugated secondary antibodies (1:500; Invitrogen, Carlsbad, CA) for 1 h at room temperature. Sections were finally rinsed thrice with PBS and then incubated with Hoechst nuclear stain in PBS for 10 minutes at room temperature. After a final rinse with PBS, they were mounted using Prolong Gold anti-fade reagent (Invitrogen) and imaged using a Zeiss (Thornwood, NY) UVLSM-Meta confocal microscope or Axiovert fluorescent microscope with the AxiocamHR camera.
SDF1 and CXCR4 expression in the normal, uninjured spinal cord
SDF1 expression following SCI
To investigate SDF1expression following SCI, we used a severe clip compression model of SCI that produces a consistent injury in mice where an initial impact is followed by persistent compression analogous to most cases of human SCI [26, 27]. At 5 weeks post SCI, SDF1 was still found in the meninges (Figure 2a) and in the dCST rostral to the lesion (Figure 2a, c). However SDF1 expression was no longer detectable in the area of the dCST caudal to the lesion site (Figure 2b, d). Longitudinal sections containing the dCST demonstrated the termination and dissipation of the tract at the lesion site (Figure 2gh). At the site of injury, SDF1 was also expressed by infiltrating cells that were largely restricted to the lesion epicenter by the glial scar (Figure 2ef).
CXCR4 expression in the injured spinal cord
Timecourse of CXCR4 expression post injury
To better understand the changes in the CXCR4 expression pattern post injury, we examined the time course of CXCR4 expression. At 24 hours post injury, we observed numerous CXCR4+ cells scattered throughout the gray and white matter, possibly reflecting the well-described microglial activation that occurs immediately following SCI (Figure 4a-c). By 4 days, however, this activation was attenuated and very few peripheral CXCR4+ cells were present at 1 week (Figure 4d-i). By 2 weeks, however, many more CXCR4+ cells appeared all around the periphery of the spinal cord in closed juxtaposition to the meninges and in the dorsal funiculus rostral to the lesion (Figure 4j, l-0). Importantly, the dorsal funiculus caudal to the lesion again had no CXCR4+ cells (Figure 4k). Throughout the timeline, CXCR4 expression persisted, but the staining was progressively somewhat attenuated in the ependymal layer
Identification of the CXCR4+ cell types
SDF1 is expressed in dCST axons
Although SDF1 has been suggested as being important in CST development, its cellular origins have not been clarified in either the normal or the injured adult spinal cord. Shechter et al described SDF1 in the dorsal horn of the spinal cord, but their immunohistochemistry associated SDF1 with GFAP. However the availability of SDF1-EGFP transgenic reporter mice allowed us to more precisely localize the chemokine, and we never found the chemokine to be co-expressed with GFAP. However we did find that SDF1 was consistently expressed by neurons contributing to the main dCST bundle of the CST but not the dorsolateral or ventral tracts. Tract tracing studies confirmed the cellular identity of the SDF1-containing fibers in the spinal cord (Figure 1e, f, g). This expression pattern is consistent with the observations of Schonemeier et al (2008) that SDF-1 was expressed by neurons in layer V of the cortex.
Function of SDF1 in the spinal cord
The expression of SDF1 in CST neurons suggests that it might have a neurotransmitter of similar function in the spinal cord. Indeed, SDF1 has been shown to act as a neuromodulator in some neural systems such as the hippocampus , and other studies have reported an upregulation of SDF1 post CNS disease . SDF-1 has been shown to be sufficient to overcome neurite outgrowth inhibition mediated by CNS myelin towards cultured postnatal dorsal root ganglion neurons. Further, local intrathecal infusion of SDF-1 following thoracic dorsal hemisection resulted in enhanced sprouting of corticospinal tract axons into white and grey matter . However, since we find that CST neurons do not express CXCR4, it seems likely that other cells that express the receptor indirectly mediated the effects of SDF1 infusion. This correlates well with our observation that CXCR4+ cells appeared to migrate towards the injured spinal cord. Our observations thus suggest that the injured CST releases SDF1 that attracts macrophages and perhaps other cells that help to stimulate CST axon regrowth.
CXCR4+ cells migrate specifically to the dorsal funiculus after SCI
The ependymal layer in the spinal cord has been reported to supply progenitors similar to the ventricular layer in the brain, augmenting general interest in the ependymal layer [28–33]. Several groups have implicated SDF1/CXCR4 signaling in the migration of CXCR4+ progenitors post injury [19–21]. However, Meletis et al deemed it unlikely that CXCR4 caused the migration of progenitors toward injury since they saw only a few ependymal cells expressing CXCR4 . Our model allowed us to easily identify cells expressing CXCR4 and we observed numerous CXCR4+ cells in the ependyma. In fact, the ependymal layer appears to express CXCR4 uniformly although this does decline somewhat subsequent to injury. One hypothesis is that neural progenitor cells migrate from the ependymal layer possibly using CXCR4 as their sensor toward areas of injury. In fact changes in levels of SDF1 after spinal cord injury were associated with changes in numbers of CD133-expressing ependymal pericytes, suggesting a possible role in regulating ependymal stem/progenitor cells . Although our static studies did not allow us to study the migration of cells away from the ependymal zone, we frequently observed CXCR4+ cells that appeared to be migrating in this fashion. However we did not find any CXCR4+ cells that had markers of neural lineages. There are several possible explanations for this. Progenitor cells are a rarer cell population than infiltrating cells post SCI and we may not be catching them with our analysis. Alternatively, progenitor cells may migrate under the influence of CXCR4 signaling and then differentiate. CXCR4+ ependymal cells themselves may not migrate away from the lesion, but may simply downregulate CXCR4 in response to other signals in the environment.
Identity of most CXCR4+ cells in the spinal cord post injury
The major component of the two migrating populations of CXCR4+ cells post injury seem to come from the same lineage. They are both infiltrating cells passing through the lesion and migrating within 2 weeks toward sources of SDF1, be it toward the meninges alone, or in between two sources of SDF1, the meninges and the dCST. Most of these CXCR4 expressing cells also express CD11b and NG2 identifying them as hematopoetic lineage cells, most likely macrophages . The role of macrophages after SCI is controversial, and they have been posited to have both beneficial and deleterious effects[37, 38]. The high expression of SDF1 by the dCST and the apparent release of the chemokine after injury suggest that attraction of CXCR4+ macrophages is part of a programmed response to injury. In turn this suggests that that modulation of the SDF1 signaling system may be important for regulating the inflammatory response after SCI.
In the adult uninjured spinal cord, SDF1 and CXCR4 are expressed in separate, nonadjacent regions: meninges and dCST vs. the ependymal layer. Following the breach in blood brain barrier post severe SCI, multiple sources of both proteins exist contributing to specific post-injury signaling. CXCR4-expressing macrophages migrate through the spinal cord toward sources of SDF1 and arrive in the peripheral spinal cord, toward the SDF1 in the meninges, and toward the intact dCST only rostral of the injury. This migration occurs between 1 and 2 weeks post injury. CXCR4-expressing ependymal cells remain post injury, but are in fewer number than in the uninjured spinal cord. Therefore, CXCR4 and SDF1 signaling does introduce a trauma-specific response post SCI and may then have a specific role.
We also acknowledge grant support through NIH grants, NS 20013 and NS 20778.
- Rossi D, Zlotnik A: The biology of chemokines and their receptors. Annu Rev Immunol. 2000, 18: 217-242. 10.1146/annurev.immunol.18.1.217.View ArticlePubMed
- Tran PB, Miller RJ: Chemokine receptors in the brain: a developing story. J Comp Neurol. 2003, 457: 1-6. 10.1002/cne.10546.View ArticlePubMed
- Li M, Ransohoff RM: Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology. Prog Neurobiol. 2008, 84: 116-131. 10.1016/j.pneurobio.2007.11.003.PubMed CentralView ArticlePubMed
- Klein RS, Rubin JB, Gibson HD, DeHaan EN, Alvarez-Hernandez X, Segal RA, Luster AD: SDF-1 alpha induces chemotaxis and enhances Sonic hedgehog-induced proliferation of cerebellar granule cells. Development. 2001, 128: 1971-1981.PubMed
- Zhu Y, Yu T, Zhang XC, Nagasawa T, Wu JY, Rao Y: Role of the chemokine SDF-1 as the meningeal attractant for embryonic cerebellar neurons. Nat Neurosci. 2002, 5: 719-720. 10.1038/nn0602-850.PubMed CentralView ArticlePubMed
- Meucci O, Fatatis A, Simen AA, Bushell TJ, Gray PW, Miller RJ: Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci USA. 1998, 95: 14500-14505. 10.1073/pnas.95.24.14500.PubMed CentralView ArticlePubMed
- Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR: Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature. 1998, 393: 595-599. 10.1038/31269.View ArticlePubMed
- Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, Bronson RT, Springer TA: Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci USA. 1998, 95: 9448-9453. 10.1073/pnas.95.16.9448.PubMed CentralView ArticlePubMed
- Chalasani SH, Sabelko KA, Sunshine MJ, Littman DR, Raper JA: A chemokine, SDF-1, reduces the effectiveness of multiple axonal repellents and is required for normal axon pathfinding. J Neurosci. 2003, 23: 1360-1371.PubMed
- Xiang Y, Li Y, Zhang Z, Cui K, Wang S, Yuan XB, Wu CP, Poo MM, Duan S: Nerve growth cone guidance mediated by G protein-coupled receptors. Nat Neurosci. 2002, 5: 843-848. 10.1038/nn899.View ArticlePubMed
- Luo Y, Cai J, Xue H, Miura T, Rao MS: Functional SDF1 alpha/CXCR4 signaling in the developing spinal cord. J Neurochem. 2005, 93: 452-462. 10.1111/j.1471-4159.2005.03049.x.View ArticlePubMed
- Bechmann I, Nitsch R: Plasticity following lesion: help and harm from the immune system. Restor Neurol Neurosci. 2001, 19: 189-198.PubMed
- Gris D, Marsh DR, Oatway MA, Chen Y, Hamilton EF, Dekaban GA, Weaver LC: Transient blockade of the CD11d/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function. J Neurosci. 2004, 24: 4043-4051. 10.1523/JNEUROSCI.5343-03.2004.View ArticlePubMed
- Hofstetter HH, Sewell DL, Liu F, Sandor M, Forsthuber T, Lehmann PV, Fabry Z: Autoreactive T cells promote post-traumatic healing in the central nervous system. J Neuroimmunol. 2003, 134: 25-34. 10.1016/S0165-5728(02)00358-2.View ArticlePubMed
- Mabon PJ, Weaver LC, Dekaban GA: Inhibition of monocyte/macrophage migration to a spinal cord injury site by an antibody to the integrin alphaD: a potential new anti-inflammatory treatment. Exp Neurol. 2000, 166: 52-64. 10.1006/exnr.2000.7488.View ArticlePubMed
- Moalem G, Leibowitz-Amit R, Yoles E, Mor F, Cohen IR, Schwartz M: Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med. 1999, 5: 49-55. 10.1038/4734.View ArticlePubMed
- Popovich PG, Guan Z, Wei P, Huitinga I, van Rooijen N, Stokes BT: Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp Neurol. 1999, 158: 351-365. 10.1006/exnr.1999.7118.View ArticlePubMed
- Stirling DP, Khodarahmi K, Liu J, McPhail LT, McBride CB, Steeves JD, Ramer MS, Tetzlaff W: Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J Neurosci. 2004, 24: 2182-2190. 10.1523/JNEUROSCI.5275-03.2004.View ArticlePubMed
- Chi L, Ke Y, Luo C, Li B, Gozal D, Kalyanaraman B, Liu R: Motor neuron degeneration promotes neural progenitor cell proliferation, migration, and neurogenesis in the spinal cords of amyotrophic lateral sclerosis mice. Stem Cells. 2006, 24: 34-43. 10.1634/stemcells.2005-0076.PubMed CentralView ArticlePubMed
- Shechter R, Ziv Y, Schwartz M: New GABAergic interneurons supported by myelin-specific T cells are formed in intact adult spinal cord. Stem Cells. 2007, 25: 2277-2282. 10.1634/stemcells.2006-0705.View ArticlePubMed
- Takeuchi H, Natsume A, Wakabayashi T, Aoshima C, Shimato S, Ito M, Ishii J, Maeda Y, Hara M, Kim SU, Yoshida J: Intravenously transplanted human neural stem cells migrate to the injured spinal cord in adult mice in an SDF-1- and HGF-dependent manner. Neurosci Lett. 2007, 426: 69-74. 10.1016/j.neulet.2007.08.048.View ArticlePubMed
- Dugas JC, Mandemakers W, Rogers M, Ibrahim A, Daneman R, Barres BA: A novel purification method for CNS projection neurons leads to the identification of brain vascular cells as a source of trophic support for corticospinal motor neurons. J Neurosci. 2008, 28: 8294-8305. 10.1523/JNEUROSCI.2010-08.2008.PubMed CentralView ArticlePubMed
- Bhattacharyya BJ, Banisadr G, Jung H, Ren D, Cronshaw DG, Zou Y, Miller RJ: The chemokine stromal cell-derived factor-1 regulates GABAergic inputs to neural progenitors in the postnatal dentate gyrus. J Neurosci. 2008, 28: 6720-6730. 10.1523/JNEUROSCI.1677-08.2008.PubMed CentralView ArticlePubMed
- Tran PB, Banisadr G, Ren D, Chenn A, Miller RJ: Chemokine receptor expression by neural progenitor cells in neurogenic regions of mouse brain. J Comp Neurol. 2007, 500: 1007-1033. 10.1002/cne.21229.PubMed CentralView ArticlePubMed
- Reiss K, Mentlein R, Sievers J, Hartmann D: Stromal cell-derived factor 1 is secreted by meningeal cells and acts as chemotactic factor on neuronal stem cells of the cerebellar external granular layer. Neuroscience. 2002, 115: 295-305. 10.1016/S0306-4522(02)00307-X.View ArticlePubMed
- Joshi M, Fehlings MG: Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 2. Quantitative neuroanatomical assessment and analysis of the relationships between axonal tracts, residual tissue, and locomotor recovery. J Neurotrauma. 2002, 19: 191-203. 10.1089/08977150252806956.View ArticlePubMed
- Joshi M, Fehlings MG: Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 1. Clip design, behavioral outcomes, and histopathology. J Neurotrauma. 2002, 19: 175-190. 10.1089/08977150252806947.View ArticlePubMed
- Meletis K, Barnabe-Heider F, Carlen M, Evergren E, Tomilin N, Shupliakov O, Frisen J: Spinal cord injury reveals multilineage differentiation of ependymal cells. PLoS Biol. 2008, 6: e182-10.1371/journal.pbio.0060182.PubMed CentralView ArticlePubMed
- Bruni JE: Ependymal development, proliferation, and functions: a review. Microsc Res Tech. 1998, 41: 2-13. 10.1002/(SICI)1097-0029(19980401)41:1<2::AID-JEMT2>3.0.CO;2-Z.View ArticlePubMed
- Mothe AJ, Tator CH: Proliferation, migration, and differentiation of endogenous ependymal region stem/progenitor cells following minimal spinal cord injury in the adult rat. Neuroscience. 2005, 131: 177-187. 10.1016/j.neuroscience.2004.10.011.View ArticlePubMed
- Attar A, Kaptanoglu E, Aydin Z, Ayten M, Sargon MF: Electron microscopic study of the progeny of ependymal stem cells in the normal and injured spinal cord. Surg Neurol. 2005, 64 (Suppl 2): S28-32. 10.1016/j.surneu.2005.07.057.View ArticlePubMed
- Takahashi M, Arai Y, Kurosawa H, Sueyoshi N, Shirai S: Ependymal cell reactions in spinal cord segments after compression injury in adult rat. J Neuropathol Exp Neurol. 2003, 62: 185-194.View ArticlePubMed
- Horky LL, Galimi F, Gage FH, Horner PJ: Fate of endogenous stem/progenitor cells following spinal cord injury. J Comp Neurol. 2006, 498: 525-538. 10.1002/cne.21065.PubMed CentralView ArticlePubMed
- Opatz J, Kury P, Schiwy N, Jarve A, Estrada V, Brazda N, Bosse F, Muller HW: SDF-1 stimulates neurite growth on inhibitory CNS myelin. Mol Cell Neurosci. 2009, 40: 293-300. 10.1016/j.mcn.2008.11.002.View ArticlePubMed
- Graumann U, Ritz MF, Rivero BG, Hausmann O: CD133 expressing pericytes and relationship to SDF-1 and CXCR4 in spinal cord injury. Curr Neurovasc Res. 2010, 7: 144-154. 10.2174/156720210791184907.View ArticlePubMed
- Guillemin GJ, Brew BJ: Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J Leukoc Biol. 2004, 75: 388-397. 10.1189/jlb.0303114.View ArticlePubMed
- Chan CC: Inflammation: beneficial or detrimental after spinal cord injury?. Recent Pat CNS Drug Discov. 2008, 3: 189-199. 10.2174/157488908786242434.View ArticlePubMed
- Rossignol S, Schwab M, Schwartz M, Fehlings MG: Spinal cord injury: time to move?. J Neurosci. 2007, 27: 11782-11792. 10.1523/JNEUROSCI.3444-07.2007.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.